|
⚲
|
| Kylin Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001418644 |
| Sale | 2009-11-09 ($2.0 M Offered, $0.1 M Sold) |
| Fund | |
| Phone | 7654126661 |
| Address | 3000 Kent Avenue West Lafayette, 47906 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Joseph Trebley | |
| Homer Pearce | |
| J Davis | |
| Christopher Meldrum |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Houstonian Capital Investments, LLC
✚
|
0.0 | |
|
Houston Michael R.W.
✚
|
0.0 | |
|
Howell Kent
✚
|
0.0 | |
|
Howell Michael W D
✚
|
0.0 | |
|
Howes Paul L
✚
|
0.0 | |
|
Howse Michael
✚
|
0.0 | |
|
HPC Lender II, LLC
✚
|
0.0 | |
|
HPH II Investments AIV Vega-Sequel, LP
✚
|
0.0 | |
|
HPI Broadway, LLC
✚
|
0.0 | |
|
Houston 101 LLC
✚
|
0.0 |